Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
April 27, 2023 01:01 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 27, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Publishes 2022 Annual Report on Form 20-F
April 20, 2023 22:43 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023 02:08 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
March 07, 2023 03:38 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock provides an update on 2022 revenue guidance
January 17, 2023 20:37 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
January 03, 2023 09:25 ET
|
Burning Rock Biotech Limited
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...
Burning Rock Reports Third Quarter 2022 Financial Results
November 15, 2022 21:20 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Admission to Trading on the London Stock Exchange
November 01, 2022 06:10 ET
|
Burning Rock Biotech Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION...
Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange
October 27, 2022 07:50 ET
|
Burning Rock Biotech Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION...
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
October 25, 2022 00:46 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...